You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 46122-0708


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 46122-0708

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

46122-0708 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Pharmaceutical Industry: Implications for NDC 46122-0708

Introduction

The pharmaceutical industry is a complex and dynamic sector, influenced by various factors including regulatory requirements, market demand, and technological advancements. Understanding the market analysis and price projections is crucial for stakeholders, especially when considering a specific National Drug Code (NDC) like 46122-0708. Here, we will delve into the broader pharmaceutical market trends and then focus on the implications for a drug with the NDC 46122-0708.

National Drug Code (NDC) Overview

The NDC is a unique, 10-digit, three-segment number assigned to each drug product. It consists of the labeler code, product code, and package code. The labeler code, assigned by the FDA, identifies the firm that manufactures or distributes the drug. The product code and package code are assigned by the firm and identify the specific strength, dosage form, and formulation of the drug, as well as the package sizes and types, respectively[1][5].

Current Market Trends in the Pharmaceutical Industry

Global Output and Sales

In 2024, the global pharmaceutical industry is expected to see an increase in output and sales, driven primarily by the Asia Pacific region. After a significant slowdown in 2023, following the high production levels of COVID-19 vaccines in 2021 and 2022, the industry is projected to grow by 4.6% in output and 5.1% in sales[3].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which treat complex or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions, are a significant driver of market growth. These medications are expected to see a price increase of 4.18% in 2024, with 42 novel specialty drugs approved in 2023 and a record number anticipated in 2024[2].

Generic and Chronic Condition Medications

Producers of generic drugs and medications for chronic conditions are also expected to find growth opportunities, particularly among aging populations. Additionally, medications for weight loss are projected to see substantial growth, with the market predicted to reach over $75 billion by 2030[3].

Price Projections and Inflation

Overall Price Trends

The pharmaceutical industry is experiencing significant price inflation. According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in 2024, driven in part by the increasing utilization of specialty and weight loss drugs[2].

Comparative Pricing

The U.S. market stands out for its high drug prices. On average, drug prices in the U.S. are 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is not just due to higher prices for the same drugs but also because the U.S. has a drug mix that skews towards more expensive compounds[4].

Implications for NDC 46122-0708

Market Positioning

To understand the price projections for a specific NDC like 46122-0708, it is essential to know the category of the drug. If it falls under specialty pharmaceuticals or treats chronic conditions, it is likely to be affected by the projected price increases in these segments.

Regulatory and Market Factors

The FDA's regulatory environment and the drug's positioning within the market will influence its pricing. For instance, if the drug is part of a highly competitive market segment, price increases might be more modest compared to drugs with fewer competitors.

Supply Chain and Distribution

The supply chain and distribution strategies of the labeler (the firm identified by the first segment of the NDC) can also impact pricing. Efficient supply chain management and strong distribution networks can help mitigate price increases driven by external factors like inflation and regulatory changes.

Case Study: Impact of Specialty Pharmaceuticals

If the drug associated with NDC 46122-0708 is a specialty pharmaceutical, it would likely be subject to the higher price inflation rates projected for this segment. Here is an example:

  • Specialty Drug Price Increase: With a projected 4.18% price increase for specialty medications, a drug priced at $100 per unit in 2023 could see a price increase to approximately $104.18 in 2024[2].

Key Takeaways

  • Global Growth: The pharmaceutical industry is expected to see growth in output and sales, driven by the Asia Pacific region.
  • Specialty Pharmaceuticals: These drugs are driving price inflation, with a projected 4.18% increase in 2024.
  • Price Disparities: Drug prices in the U.S. are significantly higher than in other regions.
  • Market Segmentation: Understanding the category of the drug (e.g., specialty, generic, chronic condition) is crucial for predicting price trends.
  • Regulatory and Supply Chain Factors: FDA regulations and supply chain efficiency can influence pricing strategies.

FAQs

Q: What is the National Drug Code (NDC) and how is it structured? A: The NDC is a 10-digit, three-segment number that identifies a drug product. It includes the labeler code, product code, and package code, each assigned by different entities[1][5].

Q: What are the key drivers of price inflation in the pharmaceutical industry in 2024? A: Specialty pharmaceuticals, including weight loss drugs and gene therapies, are significant drivers of price inflation in 2024[2].

Q: How do drug prices in the U.S. compare to other regions? A: Drug prices in the U.S. are 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].

Q: What impact does the aging population have on the pharmaceutical market? A: The aging population presents growth opportunities for producers of medications for chronic conditions and generic drugs[3].

Q: How often is the NDC Directory updated? A: The NDC Directory is updated daily and includes information on all listed drugs in their final marketed form[5].

Sources

  1. FDA: National Drug Code Database Background Information.
  2. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  3. Atradius: Pharmaceuticals Industry Trends January 2024.
  4. ASPE: ISSUE BRIEF - International Market Size and Prices.
  5. YouTube: NDC Directory (March 2015).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.